Michael Wayne Kalb

Chief Financial Officer, Amarin Corporation.

Companies

Catalyst PharmaceuticalsChief financial officer Jan 3, 2024 to now¹
Impel Neuropharma (United States)Chief financial officer May 12, 2023 to May 12, 2023²
CinCor Pharma, Inc.Chief financial officer Nov 8, 2022 to Feb 24, 2023³
Amarin CorporationChief financial officer Jul 5, 2016 to Aug 2, 2022⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 15, 2026Returned to company 13,665 shares at $31.50 of Catalyst Pharmaceuticals⁶
Jan 5, 2026Shares withheld for tax 2,080 shares of Catalyst Pharmaceuticals⁹
Jan 5, 2026Exercised options 7,139 shares of Catalyst Pharmaceuticals⁹
Nov 21, 2025Shares withheld for tax 2,485 shares of Catalyst Pharmaceuticals¹⁰
Nov 21, 2025Exercised options 6,894 shares of Catalyst Pharmaceuticals¹⁰
Jan 2, 2025Shares withheld for tax 2,941 shares of Catalyst Pharmaceuticals¹¹
Jan 2, 2025Exercised options 7,138 shares of Catalyst Pharmaceuticals¹¹
Feb 24, 2023Returned to company 202,437 shares of CinCor Pharma, Inc.⁸
Jan 26, 2023Granted 177,000 shares of CinCor Pharma, Inc.¹²
Nov 4, 2022Granted 25,437 shares of CinCor Pharma, Inc.¹³
Aug 1, 2022Shares withheld for tax 29,682 shares at $1.33 of Amarin Corporation⁵
Jul 29, 2022Shares withheld for tax 17,220 shares at $1.33 of Amarin Corporation⁵
Jul 29, 2022Exercised options 47,767 shares of Amarin Corporation⁵
Feb 28, 2022Shares withheld for tax 6,213 shares at $3.27 of Amarin Corporation¹⁴
Feb 28, 2022Exercised options 16,333 shares of Amarin Corporation¹⁴
Jan 31, 2022Shares withheld for tax 5,317 shares at $3.36 of Amarin Corporation¹⁵
Jan 31, 2022Exercised options 12,733 shares of Amarin Corporation¹⁵
Dec 31, 2021Shares withheld for tax 25,379 shares at $3.35 of Amarin Corporation¹⁶
Dec 31, 2021Exercised options 47,767 shares of Amarin Corporation¹⁶

The numbers on this page point here. Each one links to the record it came from.